Origin of Human T-lymphotrophic Virus I-positive T Cell Lines in Adult T Cell Leukemia. Analysis of T Cell Receptor Gene Rearrangement
Overview
General Medicine
Affiliations
Using the clone-specific rearrangement of the T cell receptor gene as the genetic marker of the clonotype, we analyzed the clonal origin of the interleukin 2 (IL-2)-dependent human T-lymphotrophic virus I (HTLV-I)-positive T cell lines established from various adult T cell leukemia (ATL) patients. From a patient with chronic ATL, whose leukemic cells proliferated in vitro in response to IL-2, we repeatedly established leukemic T cell clones having the same rearrangement profile of the T beta chain gene as the leukemic cells. By contrast, established cell lines from acute ATL patients had different beta chain gene rearrangements from those of the leukemic cells. These HTLV-I+ T cell lines might not be the direct progeny of the leukemic cells, but that of T cells infected either in vivo or in vitro. These IL-2-reactive nonleukemic T cells might have been selected in vitro, because their leukemic cells failed to respond to IL-2, despite the expression of IL-2 receptor. The analysis of the T cell receptor gene rearrangement may give a new approach for the elucidation of the mechanism of leukemogenesis and the origin of the HTLV-I+ T cell lines in ATL.
Current State of Therapeutics for HTLV-1.
Wang T, Hirons A, Doerflinger M, Morris K, Ledger S, Purcell D Viruses. 2024; 16(10).
PMID: 39459949 PMC: 11512412. DOI: 10.3390/v16101616.
Ichikawa T, Suekane A, Nakahata S, Iha H, Shimoda K, Murakami T Int J Mol Sci. 2024; 25(5).
PMID: 38474089 PMC: 10932150. DOI: 10.3390/ijms25052842.
HTLV-1 p12 modulates the levels of prion protein (PrP) in CD4 T cells.
Silva de Castro I, Granato A, Mariante R, Lima M, Leite A, Espindola O Front Microbiol. 2023; 14:1175679.
PMID: 37637115 PMC: 10449582. DOI: 10.3389/fmicb.2023.1175679.
Maksimova V, Wilkie T, Smith S, Phelps C, Melvin C, Yu L PLoS Pathog. 2023; 19(6):e1011459.
PMID: 37327244 PMC: 10309998. DOI: 10.1371/journal.ppat.1011459.
Precise excision of HTLV-1 provirus with a designer-recombinase.
Rojo-Romanos T, Karpinski J, Millen S, Beschorner N, Simon F, Paszkowski-Rogacz M Mol Ther. 2023; 31(7):2266-2285.
PMID: 36934299 PMC: 10362392. DOI: 10.1016/j.ymthe.2023.03.014.